BioCentury | Oct 29, 2001
Company News

Osteometer, Osteopro A/S deal

...and rheumatoid arthritis. The company combines diagnostics technologies from Osteometer with therapeutic research from Osteopro. Osteometer BioTech A/S...
BioCentury | Oct 26, 2001
Company News

Osteometer, Osteopro merge

...and cartilage diseases such as osteo and rheumatoid arthritis. Klaus Eldrup-Jorgensen, president and CEO of Osteometer...
BioCentury | Sep 18, 2000
Company News

Ostex, Diagnostic Systems Laboratories Inc., Osteometer diagnostics/imaging, musculoskeletal news

...The parties settled a suit brought by OSTX against Osteometer and Diagnostic Systems in the U.S...
...infringement of OSTX patents covering C-terminal telopeptide markers of bone resorption (CTx). Under the settlement, Osteometer...
...in the U.S. Ostex International Inc. (OSTX), Seattle, Wash. Diagnostic Systems Laboratories Inc., Houston, Texas Osteometer BioTech A/S...
BioCentury | Jul 26, 1999
Clinical News

Serum CrossLaps One Step ELISA test regulatory update

...The FDA granted marketing approval for Osteometer's test, which detects collagen fragments released into the circulation...
...into the circulation during bone resorption and predicts long term skeletal responses to antireabsorptive therapies. Osteometer Biotech A/S...
BioCentury | Feb 8, 1999
Clinical News

Ostex regulatory update

...and CTx telopeptide assays for measuring bone resorption in body fluids including serum and urine. Osteometer Biotech A/S...
BioCentury | Nov 3, 1997
Finance

Biotech hotbed in Copenhagen

...offering in the second half next year, and will probably opt for Copenhagen, he said. Osteometer Biotech A/S...
...market but is also a substantial shareholder - with 12 percent - of the company. "Osteometer...
...partnership with Boehringer Mannheim, among others, secures wide market distribution. It is our belief that Osteometer...
BioCentury | Nov 3, 1997
Finance

Private Rounds: Ice pack

...company has not ruled out either EASDAQ or NASDAQ. Also preparing for an IPO is Osteometer...
BioCentury | May 19, 1997
Clinical News

Macritonin oral salmon calcitonin data

...and, as expected, also produced significant reduction in CrossLaps. The CrossLaps test is marketed by Osteometer...
BioCentury | Sep 16, 1996
Company News

University of California other research news

...pyridinoline II and deoxypyridinoline ( Metra Biosystems Inc. , MTRA, Mountain View, Calif.) and Cross-laps (Osteometer Biotech A/S...
BioCentury | Jul 1, 1996
Company News

Cortecs International Ltd., Centre for Clinical and Basic Research, Osteometer deal

...On behalf of DLVRY, Osteometer and CCBR will conduct clinical trials of oral insulin to manage...
...pigs to optimize its oral formulation of insulin to achieve more efficient and consistent delivery. Osteometer...
...Cortecs International Ltd. (DLVRY), London, U.K. Centre for Clinical and Basic Research , Ballerup, Denmark Osteometer Biotech A/S...
Items per page:
1 - 10 of 20
BioCentury | Oct 29, 2001
Company News

Osteometer, Osteopro A/S deal

...and rheumatoid arthritis. The company combines diagnostics technologies from Osteometer with therapeutic research from Osteopro. Osteometer BioTech A/S...
BioCentury | Oct 26, 2001
Company News

Osteometer, Osteopro merge

...and cartilage diseases such as osteo and rheumatoid arthritis. Klaus Eldrup-Jorgensen, president and CEO of Osteometer...
BioCentury | Sep 18, 2000
Company News

Ostex, Diagnostic Systems Laboratories Inc., Osteometer diagnostics/imaging, musculoskeletal news

...The parties settled a suit brought by OSTX against Osteometer and Diagnostic Systems in the U.S...
...infringement of OSTX patents covering C-terminal telopeptide markers of bone resorption (CTx). Under the settlement, Osteometer...
...in the U.S. Ostex International Inc. (OSTX), Seattle, Wash. Diagnostic Systems Laboratories Inc., Houston, Texas Osteometer BioTech A/S...
BioCentury | Jul 26, 1999
Clinical News

Serum CrossLaps One Step ELISA test regulatory update

...The FDA granted marketing approval for Osteometer's test, which detects collagen fragments released into the circulation...
...into the circulation during bone resorption and predicts long term skeletal responses to antireabsorptive therapies. Osteometer Biotech A/S...
BioCentury | Feb 8, 1999
Clinical News

Ostex regulatory update

...and CTx telopeptide assays for measuring bone resorption in body fluids including serum and urine. Osteometer Biotech A/S...
BioCentury | Nov 3, 1997
Finance

Biotech hotbed in Copenhagen

...offering in the second half next year, and will probably opt for Copenhagen, he said. Osteometer Biotech A/S...
...market but is also a substantial shareholder - with 12 percent - of the company. "Osteometer...
...partnership with Boehringer Mannheim, among others, secures wide market distribution. It is our belief that Osteometer...
BioCentury | Nov 3, 1997
Finance

Private Rounds: Ice pack

...company has not ruled out either EASDAQ or NASDAQ. Also preparing for an IPO is Osteometer...
BioCentury | May 19, 1997
Clinical News

Macritonin oral salmon calcitonin data

...and, as expected, also produced significant reduction in CrossLaps. The CrossLaps test is marketed by Osteometer...
BioCentury | Sep 16, 1996
Company News

University of California other research news

...pyridinoline II and deoxypyridinoline ( Metra Biosystems Inc. , MTRA, Mountain View, Calif.) and Cross-laps (Osteometer Biotech A/S...
BioCentury | Jul 1, 1996
Company News

Cortecs International Ltd., Centre for Clinical and Basic Research, Osteometer deal

...On behalf of DLVRY, Osteometer and CCBR will conduct clinical trials of oral insulin to manage...
...pigs to optimize its oral formulation of insulin to achieve more efficient and consistent delivery. Osteometer...
...Cortecs International Ltd. (DLVRY), London, U.K. Centre for Clinical and Basic Research , Ballerup, Denmark Osteometer Biotech A/S...
Items per page:
1 - 10 of 20